Can US FDA Save Pharma From Price Controls?

FDA Commissioner Scott Gottlieb is making drug pricing a big theme of his first weeks as FDA commissioner. Will it be enough to head off other executive or legislative action on the issue?

When people talk about administrative action to control drug pricing, they don’t usually think of FDA, the agency that always says cost is not part of its mission.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access